Mark W. Grinstaff

NIH Rank #1103

NIH Funding · FY2024

Total Funding

$5M

Fiscal year 2024

Grants Awarded

Active NIH grants

National Rank

#1,103

Among 57,894 PIs

First NIH Award

2024

Year of first funding

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $5M across 9 grants · National rank #1103.

Mark W. Grinstaff's NIH grant portfolio, ranked by award amount.

5R01CA272637-03R01
Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas
Brigham and Women's Hospital
$676.4K
award amount
1R01DK141923-01R01
Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Boston University
$642.7K
award amount
5R01AR081264-03R01
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
Boston University
$629K
award amount
5R01AR079489-03R01
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
Boston University
$603.7K
award amount
5R01HL164650-03R01
Sulfated Poly-Amido-Saccharide (sulPAS) Biomaterials as Anticoagulants
Boston University
$551.2K
award amount
5R01HL159644-03R01
Biodegradable, Biocompatible Pressure Sensitive Adhesives
Boston University
$545.6K
award amount
1R01AR083161-01A1R01
A Relaxin-loaded Hydrogel for the Treatment of Hypertrophic Scars
Boston University
$526K
award amount
5U01CA265713-04U01
Precise tumor targeting with logic CAR circuits
Boston University
$525K
award amount
5T32EB006359-15T32
Translational Research in Biomaterials
Boston University
$305.5K
award amount